ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988

IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators

May 21, 1993

Anil Potti Explains: “Coming from India, I Did Not Know This Was Not The Real Rhodes Scholarship”

December 16, 2011

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Strict Regulation Of Tobacco Products Proposed in Senate

November 24, 1989